McKESSON CORPORATION Cash and Restricted Cash
McKESSON CORPORATION (MCK) had Cash and Restricted Cash of $5.26 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.26B.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.07B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.05B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.11B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $5.26B 10-Q · filed 2026-08-05 |
| 2026-03-31 | $4.07B 10-Q · filed 2026-08-05 |
| 2025-12-31 | $3.05B 10-Q · filed 2026-02-04 |
| 2025-09-30 | $4.11B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.68B 10-Q · filed 2026-08-05 |
| 2025-03-31 | $5.96B 10-Q · filed 2026-08-05 |
| 2024-12-31 | $1.28B 10-Q · filed 2026-02-04 |
| 2024-09-30 | $2.51B 10-Q · filed 2025-11-06 |
| 2024-06-30 | $2.30B 10-Q · filed 2025-08-06 |
| 2024-03-31 | $4.58B 10-K · filed 2026-05-08 |
| 2023-12-31 | $1.98B 10-Q · filed 2025-02-06 |
| 2023-09-30 | $2.52B 10-Q · filed 2024-11-07 |
| 2023-06-30 | $2.64B 10-Q · filed 2024-08-07 |
| 2023-03-31 | $4.68B 10-K · filed 2026-05-08 |
| 2022-12-31 | $2.78B 10-Q · filed 2024-02-08 |
| 2022-09-30 | $2.96B 10-Q · filed 2023-11-02 |
| 2022-06-30 | $2.34B 10-Q · filed 2023-08-02 |
| 2022-03-31 | $3.94B 10-K · filed 2025-05-09 |
| 2021-12-31 | $3.16B 10-Q · filed 2023-02-02 |
| 2021-09-30 | $2.53B 10-Q · filed 2022-11-02 |
| 2021-06-30 | $2.54B 10-Q · filed 2022-08-04 |
| 2021-03-31 | $6.40B 10-K · filed 2024-05-08 |
| 2020-12-31 | $3.73B 10-Q · filed 2022-02-03 |
| 2020-09-30 | $3.24B 10-Q · filed 2021-11-02 |
| 2020-06-30 | $2.86B 10-Q · filed 2021-08-05 |
| 2020-03-31 | $4.02B 10-K · filed 2023-05-09 |
| 2019-12-31 | $2.06B 10-Q · filed 2021-02-02 |
| 2019-09-30 | $1.36B 10-Q · filed 2020-11-03 |
| 2019-06-30 | $1.95B 10-Q · filed 2020-08-03 |
| 2019-03-31 | $2.98B 10-K · filed 2022-05-09 |
| 2018-12-31 | $1.85B 10-Q · filed 2020-02-04 |
| 2018-09-30 | $2.12B 10-Q · filed 2019-10-30 |
| 2018-06-30 | $2.20B 10-Q · filed 2019-08-01 |
| 2018-03-31 | $2.67B 10-K · filed 2021-05-12 |
| 2017-12-31 | $2.62B 10-Q · filed 2019-01-31 |
| 2017-09-30 | $2.56B 10-Q · filed 2018-10-25 |
| 2017-06-30 | $2.34B 10-Q · filed 2018-07-26 |
| 2017-03-31 | $4.25B 10-K · filed 2020-05-22 |
| 2016-03-31 | $4.99B 10-K · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |